22 January 2019
Madame Brigitte Macron visits Yposkesi, a European leader in viral vector manufacturing
The tour organized by AFM-Téléthon provided Madame Macron with a close-up of Yposkesi’s leading-edge bioproduction processes for gene therapies. Photo credit: Thomas Lang
28 November 2018
Yposkesi enters into agreement in principle for strategic partnership with Axovant to expand Axovant gene therapy manufacturing capacity
In the framework of a preferred partnership, Yposkesi plans to grant Axovant access to dedicated cGMP capacity and manufacturing resources to further support the global development and commercialization of Axovant’s…
3 July 2018
Yposkesi appoints Dr. Fraser Wright as senior advisor
With extensive experience in gene therapy vector manufacturing, Dr. Wright, scientific co-founder and former CTO of Spark Therapeutics, will support Yposkesi’s innovation in viral vector design, production and characterization.
12 February 2018